Examining the role of protein structural dynamics in drug resistance in Mycobacterium tuberculosis.

about

Examining the role of protein structural dynamics in drug resistance in Mycobacterium tuberculosis.

Item

http://www.wikidata.org/entity/Q52331616

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Examining the role of protein ...... in Mycobacterium tuberculosis.

@en

Examining the role of protein ...... in Mycobacterium tuberculosis.

@nl

type

Item

label

Examining the role of protein ...... in Mycobacterium tuberculosis.

@en

Examining the role of protein ...... in Mycobacterium tuberculosis.

@nl

prefLabel

Examining the role of protein ...... in Mycobacterium tuberculosis.

@en

Examining the role of protein ...... in Mycobacterium tuberculosis.

@nl

P1476

Examining the role of protein ...... in Mycobacterium tuberculosis.

@en

P2093

Fouad S Husseini

http://www.w3.org/2001/XMLSchema#string

Gregory M Greetham

http://www.w3.org/2001/XMLSchema#string

Kirsty Robb

http://www.w3.org/2001/XMLSchema#string

Michael Towrie

http://www.w3.org/2001/XMLSchema#string

Niall Simpson

http://www.w3.org/2001/XMLSchema#string

Rachel E Hill

http://www.w3.org/2001/XMLSchema#string

P2860

Computer "Experiments" on Classical Fluids. I. Thermodynamical Properties of Lennard-Jones Molecules

The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance

CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields

Comparison of simple potential functions for simulating liquid water

SwissParam: A fast force field generation tool for small organic molecules

A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA

A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA.

Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach

P304

8384-8399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7SC03336B

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29619185

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

5863454

http://www.w3.org/2001/XMLSchema#string